Essity on CDP's Prestigious A List for Climate
Originally published on Essity Newsroom
The hygiene and health company Essity has been awarded a place on the global non-profit environmental organization CDP's 'A List' for its leadership in corporate transparency and performance on climate.
Over 22,000 companies from 130 countries, representing two-thirds of global market capitalization, participated in CDP's 2024 questionnaire examining various criteria, including targets, governance, impact reduction initiatives, and value chain engagement. CDP rates from A to D and Essity is one of a small number of companies that made the prestigious 'A list' for Climate. For CDP forest, Essity has been awarded an A-.
'The recognition from CDP shows Essity's commitment to become net zero by 2050 and our engagement in the Science Based Target initiative (SBTi) since 2017. Improving the lives of over a billion people who use our products and services every day can only happen with a strong focus on sustainability,' says Sahil Tesfu, Essity's Chief Strategy & Sustainability Officer.
Climate change is one of the defining issues of our time, and its global effects are far-reaching. Essity is committed to becoming net zero by 2050 through full value chain decarbonization, from raw material sourcing to product use and disposal.
Essity has implemented various technologies to reduce emissions including using solar, geothermal, biogas and industrial waste heat energy sources, continuously exploring further options. As a global buyer of fresh and recycled wood-based fiber materials, Essity is dependent on healthy and resilient forests. Our target is to ensure that all wood-fiber is certified and sourced through the third-party Chain of Custody systems FSC and PEFC.
CDP holds the largest environmental database in the world, and its annual environment-related data collection and assessment process is widely recognized as the leading benchmark when it comes to ensuring the transparency of companies' environmental activities.
For additional information, please contact: Karl Stoltz, Public Relations Director, +46 (0) 70 942 63 38, [email protected]
About Essity
Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.
Visit 3BL Media to see more multimedia and stories from Essity / TORK
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
TeachTown's enCORE Named "Special Education Solution of the Year" in 7th Annual EdTech Breakthrough Awards Program
WOBURN, Mass., June 4, 2025 /PRNewswire/ -- TeachTown, a leading provider of special education curriculum for students with moderate to severe disabilities, announces today that enCORE has been recognized as the "Special Education Solution of the Year" in the 7th annual EdTech Breakthrough Awards program conducted by EdTech Breakthrough, a leading market intelligence organization that recognizes the top companies and solutions in the global educational technology market. TeachTown's enCORE is a K-12 standards-first, adapted core curriculum that provides students with moderate to severe disabilities access to the general education curriculum. enCORE uses adapted grade-aligned content, high-quality, differentiated literature and integrated technology. The comprehensive curriculum offers a blended learning approach to meet the wide array of learning and behavioral needs in a classroom through hands-on, teacher-led instruction and technology-facilitated lessons. "With enCORE, instruction is tailored to individual student goals and learning objectives. Academics and behaviors improve because learning is 'just right' for each student," said Steve Johansson, managing director, EdTech Breakthrough. "With enCORE, schools now have the opportunity to give their students with moderate to severe disabilities equitable and inclusive access to the general education curriculum." The mission of the EdTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of educational technology categories, including Student Engagement, School Administration, Adaptive Learning, STEM Education, Remote Learning, Career Preparation and many more. This year's program attracted thousands of nominations from over 15 different countries throughout the world. "enCORE was developed by clinical and education experts to deliver flexible, personalized learning that supports every student's success," said Richard Becker, CEO of TeachTown. "We're honored to receive the 'Special Education Solution of the Year' award from EdTech Breakthrough, and we remain committed to making a meaningful impact for students with moderate to severe disabilities and the educators who serve them." About TeachTown TeachTown, backed by L Squared Capital Partners, is focused on providing software and solutions for students with disabilities, including those diagnosed with Autism Spectrum Disorder and Intellectual and Developmental Disabilities. Media ContactMegan Gilsonmgilson@ View original content to download multimedia: SOURCE TeachTown Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Lotus Therapeutics Appoints Leslie Felix as Chief Growth Officer
Industry veteran to drive strategic expansion and innovation in complex generics BOCA RATON, Fla. , June 4, 2025 /PRNewswire/ -- Lotus Therapeutics, the generic division of Speranza Therapeutics, proudly announces the appointment of Leslie Felix as Chief Growth Officer. With over 25 years of executive experience in the pharmaceutical sector, Felix brings a proven track record in the generics market, poised to steer Lotus Therapeutics through its next phase of growth and innovation. Established in 2024, Lotus Therapeutics is committed to revolutionizing access to life-changing medications by focusing on the development of complex and unique generic formulations. The company's mission centers on addressing unmet medical needs through innovative therapies, ensuring that advancements are accessible to those who need them most. Felix has successfully led P&L operations exceeding $300 million and has held key senior positions at leading pharmaceutical companies, where his go-to-market strategies solidified their leadership in the generics space. In 2020, he founded the Authorized Generics Coalition, reinforcing his dedication to industry advancement and patient access. "Leslie's depth of expertise and forward-thinking approach are exactly what Lotus Therapeutics needs as we enter a pivotal phase of expansion," said Sal Rafanelli, CEO of Lotus Therapeutics. "We are excited to welcome him to our leadership team and look forward to the impact he will make in driving our strategic growth initiatives." As Chief Growth Officer, Felix will oversee strategic partnerships and market development efforts, positioning Lotus Therapeutics for long-term success. His leadership is expected to enhance the company's capabilities in managing post-Loss of Exclusivity (LOE) assets and expanding its portfolio of complex generics. Lotus Therapeutics' foundation is built upon a legacy of innovation, with its executive team having previously founded BioMatrix®, a leader in specialty infusion services, and Speranza Therapeutics, known for launching ST Genesis®. This heritage underscores the company's commitment to delivering affordable, high-quality therapies that make a meaningful impact on patient lives For more information about Lotus Therapeutics and its mission to transform patient care with innovative generics, visit Media Contact: Lauren Saccone, lsaccone@ View original content to download multimedia: SOURCE Speranza Therapeutics
Yahoo
3 hours ago
- Yahoo
Volvo Cars sales plunge 12% in May as tariff challenges continue
Volvo Cars announced worldwide sales of 59,822 cars in May, which was a decrease of 12% compared with the same month in 2024. This was partly due to the company struggling with recently imposed US automotive tariffs. Electrified models — both plug-in hybrids and fully electric vehicles — made up 44% of all car sales in May. This was a fall from 66% in May 2024. While fully electric models made up 21% of all May sales, plug-in hybrid models accounted for 23%. The best-selling model in May was the XC60, which sold 19,408 units — a slight dip from the 20,507 units sold in the same month last year. The XC40/EX40 model took second place, with 14,892 units sold — an increase on May 2024's 13,640 units. The third best-selling model was the XC90 with 8,794 units sold in May 2025. By contrast, 9,072 units of this model were sold in May 2024. As of December 2024, Volvo Cars had about 42,600 full-time employees, with its head office based in Gothenburg, Sweden, and production plants across the US, Belgium and in China. Volvo Cars also recently announced that it would be slashing 3,000 jobs, as part of wide-ranging cost-cutting measures, which are expected to save the company about SEK 18 billion (€1.6bn). These layoffs will primarily affect office-based positions in Sweden, which make up around 15% of Volvo Cars' white collar workforce. Out of these 3,000 layoffs, around 1,000 will be consultant positions. Earlier in May, the company laid off 5% of its staff in its Ridgeland, South Carolina facility, which accounted for 125 roles. Volvo Cars said in a press release about the redundancies on its website: 'These structural changes are necessary for Volvo Cars to deliver on its long-term strategy, strengthening its foundations for profitable growth. 'Volvo Cars remains firm on its ambition of becoming a fully electric car company, as fully electric is the fastest growing market segment and Volvo Cars is a leader in this transition.' Back in 2021, the company revealed that all its models would be electric by the end of the decade. However, it has pushed back this goal, citing rising uncertainties due to electric vehicle (EV) tariffs in many markets. Apart from tariffs, slower European sales and the higher cost of materials have also affected several major car companies in Europe. Nissan, Ford, General Motors, Volkswagen, Tesla and Stellantis have all announced layoffs in the last few months, as car companies scramble to become more efficient and adaptive in the current uncertain economic environment. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
